NV-387 in New Jersey. It is an antiviral drug that treats RSV, COVID, Long COVID, Influenza, and other respiratory viral infections. It also treats covid 19 and measles. It is not yet available for humans as it is still under clinical tests. It is being developed by NanoViricides.

NV-387 is a remarkable antiviral drug, in that it not only attacks the virus, but also reduces inflammation, calming the human immune system so that untoward effects do not take place,” said Anil R. Diwan, Ph.D., President and Chairman, adding, “NV-387 treatment reduces inflammation markers, particularly, IL-6, thereby protecting lungs. This reduction in inflammation and cyto-protective effect of NV-387 would also help minimize the risk of reawakening cancer, based on these reported studies. – You can read it further here.

NV-387 in New Jersey

As of this writing, the antiviral drug is still in clinical stage phase 2. It is already passed the stage 1, so it is being prepared for next stage.

Last May 2025, NV-387 cleared for its Phase II clinical trial application from the National Ethics Committee of the Democratic Republic of Congo –

NV-387 was found to be highly effective in increasing survival in lethal animal models of influenza virus, surpassing existing drugs Tamiflu®, Rapivab® and Xofluza® by a large margin.

NV-387 led to a complete cure of lethal RSV lung infection in an animal model study. There is no approved drug for RSV treatment.

NV-387 was found to be highly effective in increasing survival in lethal animal models of Coronavirus infection (a stand-in model for SARS-CoV-2 infection), surpassing existing drug remdesivir by a large margin… BIOSPACE.

In otherwords, it has been tested to animals but soon to humans. The essence of clinical tests is to make sure it will benefit the patients in the long run.

TIPS AND WARNINGS:

• NV-387 is not yet available as it is under clinical tests.
• New Jersey has treatments for any respiratory diseases. It so happened that NV-387 is the newest development in antiviral drug development for those diseases. After the thorough tests and approvals, it will soon be used to humans.
• Prevention is better than cure.
• Treatment is different from cure!